True North Advisors LLC Boosts Stock Holdings in The Procter & Gamble Company (NYSE:PG)

True North Advisors LLC increased its position in The Procter & Gamble Company (NYSE:PGFree Report) by 6.1% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,359 shares of the company’s stock after acquiring an additional 364 shares during the period. True North Advisors LLC’s holdings in Procter & Gamble were worth $1,101,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. HighPoint Advisor Group LLC bought a new stake in Procter & Gamble in the 4th quarter worth about $17,696,000. Bayesian Capital Management LP grew its stake in shares of Procter & Gamble by 43.0% in the fourth quarter. Bayesian Capital Management LP now owns 52,840 shares of the company’s stock worth $7,743,000 after acquiring an additional 15,900 shares during the period. Steele Capital Management Inc. bought a new position in Procter & Gamble during the first quarter valued at approximately $204,000. United Advisor Group LLC purchased a new stake in Procter & Gamble in the fourth quarter worth approximately $3,463,000. Finally, GAMMA Investing LLC grew its position in Procter & Gamble by 67.2% in the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock worth $4,420,000 after purchasing an additional 10,777 shares during the period. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Trading Up 0.1 %

Shares of PG opened at $168.39 on Wednesday. The firm has a market cap of $397.42 billion, a P/E ratio of 27.48, a price-to-earnings-growth ratio of 3.73 and a beta of 0.41. The company has a 50 day simple moving average of $171.22 and a two-hundred day simple moving average of $166.63. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The Procter & Gamble Company has a 1 year low of $141.66 and a 1 year high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. During the same period in the prior year, the company earned $1.37 earnings per share. The firm’s revenue was down .1% on a year-over-year basis. On average, equities analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.39%. Procter & Gamble’s payout ratio is 65.69%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of the company’s stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the completion of the sale, the chief executive officer now directly owns 263,537 shares in the company, valued at approximately $44,508,763.93. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 383,194 shares of company stock worth $65,140,718 over the last 90 days. 0.17% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Dbs Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Stifel Nicolaus boosted their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Royal Bank of Canada increased their price objective on shares of Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research note on Wednesday, July 31st. JPMorgan Chase & Co. raised their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Finally, BNP Paribas assumed coverage on shares of Procter & Gamble in a research report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price target on the stock. Nine research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $175.89.

View Our Latest Stock Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.